| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Semerjian Harout, Director
Bought 53,500 shares ($50.8K) |
| 10 Nov 2026 | SCHEDULE 13G |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026 |
| 28 Oct 2026 |
8-K: Other Events
FOSTER CITY, Calif., – October 28, 2026 – Geron Corporation (Nasdaq: GERN), a commercial-stage hematology biopharmaceutical company, today announced the decision to discontinue the Phase 3 IMpactMF trial evaluating imetelstat in JAK inhi... |
| 01 Oct 2026 |
Form 4: Spiegel Robert J., Director
Received 6,351 shares as a grant or award ($7.81K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 | SCHEDULE 13G |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Achieved $57.5 million in RYTELO® (imetelstat) net product revenue in Q2 2026, an increase of 11% compared to Q1 2026 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 | S-8 |
| 01 Jul 2026 |
Form 4: Spiegel Robert J., Director
Received 6,103 shares as a grant or award ($7.81K) |
| 27 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
Successor to and Continuation of Prior Plans. The Plan is intended as the successor to and continuation of the Geron Corporation 2011 Incentive Award Plan (the “2011 Plan”) and the Geron Corporation 1992 Stock Option Plan (the “1992 Plan... |
| 26 May 2026 |
Form 4: Spiegel Robert J., Director
Granted 220,000 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: O'Farrell Elizabeth G., Director
Granted 220,000 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Molineaux Susan, Director
Granted 220,000 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: McDonald John F, Director
Granted 220,000 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Bir Dawn Carter, Director
Granted 220,000 Stock Option (right to buy) |
| 15 May 2026 | SCHEDULE 13G/A |
| 08 May 2026 | SCHEDULE 13G/A |
Loading...